Brief: Nanobiotix Enters Final Contract Negotiations On NBTXR3 With Major Global Pharmaceutical Company
05/05/2023 06:33
May 5 (Reuters) - Nanobiotix SA NANOB.PA :
* ENTERING FINAL CONTRACT NEGOTIATIONS FOLLOWING AGREEMENT
TO
NON-BINDING TERM SHEET FOR DEVELOPMENT AND COMMERCIALIZATION OF
NBTXR3 WITH A MAJOR GLOBAL PHARMACEUTICAL COMPANY
Source text https://bit.ly/3nAW8ub
Further company coverage: NANOB.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Nanobiotix SA
See all newsBrief: Nanobiotix S.A. H1 Net Income EUR -34.3 Million
France's Nanobiotix H1 net loss widens on lower revenue, absence of 2025 one-off gain
Brief: Nanobiotix Reports Encouraging Full Phase 1 Results For Lung Cancer Drug JNJ-1900
Brief: Nanobiotix Q1 Cash And Cash Equivalents Of €42.1 Mln
Brief: NANOBIOTIX Announces Closing Of Global Offering